ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 157 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q4 2020. The put-call ratio across all filers is 1.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $21,000 | -86.4% | 12,076 | -83.1% | 0.00% | – |
Q3 2021 | $154,000 | -36.1% | 71,468 | +3.8% | 0.00% | – |
Q2 2021 | $241,000 | -64.3% | 68,860 | +0.6% | 0.00% | – |
Q1 2021 | $675,000 | -32.7% | 68,455 | -26.0% | 0.00% | – |
Q4 2020 | $1,003,000 | -40.1% | 92,492 | -43.1% | 0.00% | -100.0% |
Q3 2020 | $1,674,000 | -19.1% | 162,438 | +63.9% | 0.00% | 0.0% |
Q2 2020 | $2,070,000 | +314.0% | 99,110 | +93.9% | 0.00% | – |
Q1 2020 | $500,000 | -52.8% | 51,119 | -44.4% | 0.00% | -100.0% |
Q4 2019 | $1,060,000 | +1506.1% | 91,947 | +653.8% | 0.00% | – |
Q3 2019 | $66,000 | -53.8% | 12,197 | +1.6% | 0.00% | – |
Q2 2019 | $143,000 | +120.0% | 12,009 | -3.6% | 0.00% | – |
Q1 2019 | $65,000 | +58.5% | 12,458 | -4.0% | 0.00% | – |
Q4 2018 | $41,000 | -50.0% | 12,974 | -16.7% | 0.00% | – |
Q2 2018 | $82,000 | +134.3% | 15,568 | +29.9% | 0.00% | – |
Q4 2016 | $35,000 | -41.7% | 11,982 | -18.2% | 0.00% | – |
Q3 2016 | $60,000 | -61.8% | 14,647 | -70.5% | 0.00% | – |
Q2 2016 | $157,000 | – | 49,696 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BML Capital Management, LLC | 3,915,000 | $5,872,500 | 5.39% |
Versant Venture Management, LLC | 5,068,233 | $7,602,350 | 4.04% |
Sonic GP LLC | 2,000,000 | $3,000,000 | 2.91% |
COMMODORE CAPITAL LP | 10,000,000 | $15,000,000 | 1.75% |
VR Adviser, LLC | 6,573,300 | $9,859,950 | 1.04% |
AIGH Capital Management LLC | 1,323,985 | $1,985,977 | 0.94% |
Newtyn Management, LLC | 1,025,000 | $1,537,500 | 0.38% |
Worth Venture Partners, LLC | 331,668 | $497,502 | 0.30% |
Acuitas Investments, LLC | 291,169 | $436,754 | 0.26% |
Quinn Opportunity Partners LLC | 398,298 | $597,447 | 0.08% |